India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
Brazil Dengue Vaccine Deaths Trigger Safety Concerns Why in the News ? The suspension of Brazil’s Butantan-DV dengue vaccine after reports of severe adverse events and two deaths has raised concerns about the safety of India’s upcoming DengiAll vaccine, as both are based on similar vaccine technology. This development highlights the importance of the precautionary …
Read MoreWhy in the news? The ICMR disassociated from a BHU study on Covaxin, citing no financial or technical support and critical design flaws. ICMR criticized the study for lacking a control group and proper documentation of adverse events. Source:IndiaToday Key Points about COVAXIN: “COVAXIN is India’s first indigenous COVID-19 vaccine developed by Bharat Biotech in …
Read MoreWhy in the news? A study published in Springer Nature highlights that adolescent girls and individuals with co-morbidities are at increased risk of adverse events after receiving Bharat Biotech’s Covexin (BBV152) vaccine. Nearly one-third of participants in the observational study reported adverse events of special interest (AESI). Conducted by Banaras Hindu University, the study titled …
Read MoreWhy in the news? AstraZeneca, known for its COVID-19 vaccine Covishield, withdraws globally due to rare side-effects and surplus availability of updated vaccines. source:reuters Key Points:AstraZeneca Withdraws COVID-19 Vaccine: AstraZeneca, in collaboration with Oxford University, has commenced the global withdrawal of its COVID-19 vaccine. Marketed as ‘Covishield’ in India through a partnership with the Serum …
Read More
